2nd Cell Therapy Analytical Development Summit Europe
![2nd Cell Therapy Analytical Development Summit Europe](/sites/default/files/styles/x_large/public/2023-05/2nd-Cell-Therapy-Analytical-Development-Summit-Europe%5B1%5D.jpg?itok=q_QfEJn6)
Following the success of last year’s inaugural meeting, the 2nd Cell Therapy Analytical Development Summit Europe heads to Amsterdam this year as the only cell therapy-focused, industry-facing, European-specific summit in the space.
With FDA regulatory holds on release assays and potency forming a prevailing bottleneck in the cell therapy space, there has never been a more important time for the European cell therapy community to unite to implement gold standard analytical development, effectively communicate with the EMA and secure market approval.
Join 100+ analytical development, CMC and process development industry experts this September as they look to advance multi-region access, achieve consistent and scalable assay development and drive analytical standards to bring safe, high-quality cell therapies to patients across the European territories.
Hear from expert speakers across 3 jam-packed days of data-driven presentations and gain control of your manufacturing processes, assay development and analytical strategy with key thought leaders from the likes of Takeda, Novo Nordisk, Cellectis and Novartis.